Evidence map›Paper›PMID 34207462›Full record

ArticleCells2021

Mechanical Control of Cell Migration by the Metastasis Suppressor Tetraspanin CD82/KAI1.

Laura Ordas, Luca Costa, Anthony Lozano, Christopher Chevillard, Alexia Calovoulos, Diala Kantar, Laurent Fernandez, Lucie Chauvin, Patrice Dosset, Christine Doucet and 5 more

Open access · goldAbstract read
In one paragraph

Article in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. The dysadherin/FAK axis promotes individual cell migration in colon cancer.International journal of biological sciences · 2024
    Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 2 countries.

Laura OrdasCentre de Biologie Structurale (CBS), CNRS, INSERM, University Montpellier, 34090 Montpellier, France.
Luca CostaCentre de Biologie Structurale (CBS), CNRS, INSERM, University Montpellier, 34090 Montpellier, France.ORCID 0000-0002-4527-0034
Anthony LozanoCentre de Biologie Structurale (CBS), CNRS, INSERM, University Montpellier, 34090 Montpellier, France.ORCID 0000-0002-9749-0573
Christopher ChevillardCentre de Biologie Structurale (CBS), CNRS, INSERM, University Montpellier, 34090 Montpellier, France.
Alexia CalovoulosCentre de Biologie Structurale (CBS), CNRS, INSERM, University Montpellier, 34090 Montpellier, France.ORCID 0000-0002-1038-3442
Diala KantarInstitut de Recherche en Cancérologie de Montpellier (IRCM), Inserm U1194-University Montpellier-Institut Régional du Cancer de Montpellier (ICM), 34298 Montpellier, France.
Laurent FernandezCentre de Biologie Structurale (CBS), CNRS, INSERM, University Montpellier, 34090 Montpellier, France.
Lucie ChauvinCentre de Recherche de Biologie Cellulaire de Montpellier (CRBM), CNRS UMR 5237, University Montpellier, 34293 Montpellier, France.
Patrice DossetCentre de Biologie Structurale (CBS), CNRS, INSERM, University Montpellier, 34090 Montpellier, France.
Christine DoucetCentre de Biologie Structurale (CBS), CNRS, INSERM, University Montpellier, 34090 Montpellier, France.
Lisa Heron-MilhavetInstitut de Recherche en Cancérologie de Montpellier (IRCM), Inserm U1194-University Montpellier-Institut Régional du Cancer de Montpellier (ICM), 34298 Montpellier, France.ORCID 0000-0002-7099-0850
Elena OdintsovaInstitute of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.ORCID 0000-0003-4330-4568
Fedor BerditchevskiInstitute of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
Pierre-Emmanuel MilhietCentre de Biologie Structurale (CBS), CNRS, INSERM, University Montpellier, 34090 Montpellier, France.
Christine BénistantCentre de Biologie Structurale (CBS), CNRS, INSERM, University Montpellier, 34090 Montpellier, France.
Centre National de la Recherche Scientifique · FRInserm · FRUniversity of Birmingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The plasma membrane is a key actor of cell migration. For instance, its tension controls persistent cell migration and cell surface caveolae integrity. Then, caveolae constituents such as caveolin-1 can initiate a mechanotransduction loop that involves actin- and focal adhesion-dependent control of the mechanosensor YAP to finely tune cell migration. Tetraspanin CD82 (also named KAI-1) is an integral membrane protein and a metastasis suppressor. Its expression is lost in many cancers including breast cancer. It is a strong inhibitor of cell migration by a little-known mechanism. We demonstrated here that CD82 controls persistent 2D migration of EGF-induced single cells, stress fibers and focal adhesion sizes and dynamics. Mechanistically, we found that CD82 regulates membrane tension, cell surface caveolae abundance and YAP nuclear translocation in a caveolin-1-dependent manner. Altogether, our data show that CD82 controls 2D cell migration using membrane-driven mechanics involving caveolin and the YAP pathway.

Indexed as

Caveolin 1Cell AdhesionCell LineCell Line, TumorCell MembraneCell MovementHumansKangai-1 ProteinMechanotransduction, CellularMembrane ProteinsNeoplasm MetastasisNeoplasmsSignal TransductionStress FibersTetraspaninsTranscription FactorsCaveolin 1CD82 protein, humanKangai-1 ProteinMembrane ProteinsTetraspaninsTranscription Factorsactincaveolinscell migrationfocal adhesionsmechanotransductionplasma membranetetraspaninsYAP

Identifiers

PMID34207462
PMCPMC8234748
OpenAlexW3175944093

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.